Randomised response-adaptive designs in clinical trials / Anthony C. Atkinson and Atanu Biswas.
Material type:
TextSeries: Monographs on statistics and applied probability ; 130Publication details: Boca Raton : CRC Press, c2014.Description: xvi, 323 p. : illustrations; 24 cmISBN: - 9781584886938 (hardcover : alk. paper)
- 000SB:615.50724 23 At875
| Item type | Current library | Call number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|
| Books | ISI Library, Kolkata ISI Scientist Publication | 000SB:615.50724 At875 (Browse shelf(Opens below)) | Available | 135559 | |||
| Books | ISI Library, Kolkata | 000SB:615.50724 At875 (Browse shelf(Opens below)) | Available | 135558 |
Browsing ISI Library, Kolkata shelves Close shelf browser (Hides shelf browser)
| No cover image available | No cover image available | |||||||
| 000SB:615.5 Y94 Bayesian designs for phase I-II clinical trials / | 000SB:615.50724 B215 Inference based on surrogate endpoints in clinical trials with binary responses / | 000SB:615.50724 At875 Randomised response-adaptive designs in clinical trials / | 000SB:615.50724 At875 Randomised response-adaptive designs in clinical trials / | 000SB:615.58 Sv968 Modern adaptive randomized clinical trials : | 000SB:615.704 G441 Statistical methods for drug safety / | 000SB:615 B942 Statistics in the pharmaceutical industry |
Includes bibliographical references (pages 299-318) and index.
1. Adaptive design : controversies and progress --
2. Randomized balanced sequential treatment allocation --
3. Response-adaptive designs for binary responses --
4. Response-adaptive designs for continuous responses --
5. Response-adaptive designs for longitudinal responses --
6. Optimum biased-coin designs with covariates --
7. Optimum response-adaptive designs with covariates --
8. Optimal response-adaptive designs with constraints --
9. Adaptive design : further important issues--
A Optimum design--
Bibliography--
Index.
Response-adaptive designs, which aim to reduce the number of patients receiving inferior treatments, are popular in Phase III clinical trials. This book provides an overview of the research in this area.
There are no comments on this title.
